Hematopoietic Stem Cell TransplantationTransplantation, AutologousStem Cell TransplantationTransplantation, HomologousTransplantation ConditioningPeripheral Blood Stem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsGraft vs Host DiseaseTreatment OutcomeMultiple MyelomaCombined Modality TherapyMelphalanRemission InductionStem CellsHematologic NeoplasmsBone Marrow TransplantationMyeloablative AgonistsRecurrenceSalvage TherapyDisease-Free SurvivalCyclophosphamideCytarabineBusulfanEtoposideSurvival RateTransplantation ChimeraSurvival AnalysisLymphoma, Non-HodgkinHodgkin DiseaseRetrospective StudiesWhole-Body IrradiationGraft SurvivalHematopoietic Stem Cell MobilizationLeukemia, Myeloid, AcuteTissue DonorsHematopoietic Stem CellsVincristineGraft vs Leukemia EffectPrognosisCarmustineFollow-Up StudiesAntineoplastic AgentsVidarabineLiver TransplantationThiotepaNeoplasm, ResidualMyelodysplastic SyndromesTime FactorsGraft vs Tumor EffectHistocompatibility TestingDoxorubicinCord Blood Stem Cell TransplantationAntigens, CD34LeukemiaImmunosuppressive AgentsBone Marrow PurgingPrecursor Cell Lymphoblastic Leukemia-LymphomaMesenchymal Stem Cell TransplantationGranulocyte Colony-Stimulating FactorLymphocyte TransfusionAntibodies, Monoclonal, Murine-DerivedLymphoma, Mantle-CellLeukemia, MyeloidCell TransplantationLymphomaLymphoma, FollicularAmyloidosisHistocompatibilitySiblingsDexamethasoneIfosfamideAcute DiseaseAntineoplastic Agents, AlkylatingLeukemia, Myelogenous, Chronic, BCR-ABL PositiveKidney TransplantationCytomegalovirus InfectionsEmbryonic Stem CellsBoronic AcidsLymphocyte DepletionAntilymphocyte SerumPyrazinesProspective StudiesMinor Histocompatibility AntigensPrednisoneT-LymphocytesHepatic Veno-Occlusive DiseaseAdult Stem CellsThalidomideChimerismLeukapheresisVirus ActivationIdarubicinChemotherapy, AdjuvantInduction ChemotherapyAutograftsLymphoma, T-Cell, PeripheralHematologic DiseasesFatal OutcomeAntibodies, MonoclonalHLA Antigens